AVGR - Rasio utang marang kapitalisasi buku Avinger Inc.

Logo korporat perusahaan Avinger, Inc. (AVGR)

Avinger, Inc. (AVGR) leverages unique Pantheris technologies that enable surgeons to clear arteries with high precision, driving business growth. The company's balance sheet financial leverage demonstrates a current reliance on borrowings, where the 1.39 level reflects the current magnitude of the debt load. Despite the management's technical expertise, scaling remains difficult, and moderate revenue from catheter sales is currently constraining aggressive capital expansion.

Avinger, Inc. - Utang-utang marang kapitalisasi buku AVGR (periode 04.07.2022 - 22.02.2025)
Barang unggulan Avinger Inc

This ratio determines the degree of capital structure dependence on borrowed funds relative to equity. The trend of the company's total debt relative to its book capitalization allows for an assessment of excessive leverage risk. This metric measures the balance between financial stability and the cost of asset ownership. For Avinger, Inc. (AVGR), a moderate debt load provides the resources necessary to develop eco-friendly production of laser systems. Monitoring this indicator confirms ethical capital management during the modernization of factories.

Pesaing Avinger, Inc.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang-utang marang kapitalisasi buku|ICCM - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku pulmonx.com|TELA Bio (TELA) - Rasio utang marang nilai buku|CTSO: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ZYXI (Zynex Inc)|Utang marang nilai buku electrocore.com (ECOR)|Utang-utang marang kapitalisasi buku RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Utang-utang marang kapitalisasi buku|ICU - Rasio utang marang kapitalisasi buku|IRIDEX Corporation (IRIX) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku ibs.inc INBS|Beyond Air (XAIR) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku PFSA (Profusa Inc)|Utang-utang marang nilai buku SSKN|GCTK: Rasio utang marang kapitalisasi buku|Utang marang aset resik NanoVibronix Inc. NAOV|Utang marang nilai buku VERO (Venus Concept Corp)|Utang-utang marang kapitalisasi buku Nuwellis Corp NUWE|Utang-utang marang kapitalisasi buku AEMD (Aethlon Medical)|ASXC: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku